Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
5
×
clinical trials
life sciences
national blog main
biotech
boston blog main
fda
national top stories
new york blog main
boston top stories
eli lilly
new york top stories
abbvie
allergan
alnylam pharmaceuticals
inclisiran
indiana blog main
indiana top stories
national
new york
novartis
pcsk9 inhibitors
raleigh-durham blog main
raleigh-durham top stories
regeneron pharmaceuticals
10x genomics
alirocumab
alprazolam
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avexis
biogen
biohaven
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
What
fda
5
×
drug
medicines
new
cholesterol
medco
migraine
won
acquire
acute
addresses
adults
agreed
allergan
approval
approved
august
billion
bio
biotech
bringing
brings
busy
cash
causes
class
clears
closer
company
compound
condition
days
deal
decades
decisions
devices
drugs
eli
filing
friday
Language
unset
5
×
Current search:
amgen
×
unset
×
fda
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More